In colon tumors, immunohistochemical analysis demonstrated that regions of tumor that stained positive for pimonidazole, a hypoxia probe, displayed decreased levels of the proapoptotic Bcl family members, BH3-interacting domain death agonist (BID) and Bcl2-associated X (BAX). Here, BID is linked to colonic neoplasm.